Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.lotuseye.org | |
Market Cap | 180.66 Cr. | |
Enterprise Value(EV) | 171.20 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.94 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 44.73 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 63.07 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 28.25 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.08 | Calculated using Price: 86.87 |
Dividend Yield | 0.58 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.08 Cr. | 20,796,330 Shares |
FaceValue | 10 | |
About Lotus Eye Hospital And Institute Ltd. | ||
Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.'on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited' upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore. |
1 Day |
|
-0.18% |
1 Week |
|
+3.59% |
1 Month |
|
-1.07% |
3 Month |
|
-3.24% |
6 Month |
|
+10.09% |
1 Year |
|
+1.85% |
2 Year |
|
+78.78% |
5 Year |
|
+214.46% |
10 Year |
|
+1097.96% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -3.93 | 0.20 | 0.89 | 3.47 | 1.41 | 2.10 | 3.02 | 5.56 | 7.27 | |
Return on Capital Employed (%) | -4.14 | 0.27 | 1.13 | 3.71 | 1.66 | 3.32 | 4.07 | 8.00 | 10.43 | |
Return on Assets (%) | -3.45 | 0.18 | 0.81 | 3.12 | 1.25 | 1.89 | 2.71 | 4.99 | 6.58 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 49 | 49 | 50 | 51 | 50 | 51 | 53 | 55 | 58 | 59 | |
Non Curr. Liab. | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
Curr. Liab. | 6 | 5 | 4 | 7 | 6 | 6 | 6 | 6 | 5 | 8 | |
Minority Int. | |||||||||||
Equity & Liab. | 56 | 55 | 55 | 57 | 56 | 57 | 58 | 61 | 63 | 66 | |
Non Curr. Assets | 51 | 48 | 48 | 49 | 49 | 47 | 45 | 48 | 48 | 50 | |
Curr. Assets | 5 | 6 | 7 | 8 | 7 | 11 | 14 | 13 | 15 | 16 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 56 | 55 | 55 | 57 | 56 | 57 | 58 | 61 | 63 | 66 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 30 | 31 | 34 | 38 | 38 | 41 | 32 | 39 | 47 | 49 | |
Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Income | 30 | 32 | 35 | 39 | 39 | 41 | 33 | 40 | 48 | 50 | |
Total Expenditure | -29 | -28 | -31 | -34 | -35 | -37 | -29 | -33 | -39 | -41 | |
PBIDT | 2 | 4 | 4 | 5 | 4 | 5 | 4 | 7 | 9 | 9 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -4 | -4 | -3 | -3 | -3 | -3 | -2 | -3 | -3 | -3 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | -2 | |
Exceptional Items | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |||
PAT | -2 | 0 | 0 | 2 | 1 | 1 | 2 | 3 | 4 | 4 | |
Adjusted EPS | -1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 2 | 2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 4 | 2 | 3 | 3 | 6 | 4 | 5 | 3 | 4 | 4 | |
Cash Fr. Inv. | -5 | -5 | -1 | -1 | -4 | -4 | -1 | 0 | -4 | -2 | |
Cash Fr. Finan. | -1 | 2 | -1 | 0 | -2 | -1 | 0 | 0 | -2 | -2 | |
Net Change | -1 | 0 | 2 | 2 | 0 | -1 | 4 | 3 | -1 | 0 | |
Cash & Cash Eqvt | 1 | 1 | 2 | 3 | 4 | 3 | 7 | 10 | 9 | 9 |
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Of financial results approved by the Board of directors in its meeting held on 14th November 2023 |
Tue, 14 Nov 2023
Outcome Of Board Meeting Held On November 14Th 2023 Approved unaudited standalone results for the quarter and period ended September 30th 2023 |
Tue, 14 Nov 2023
Outcome Of Board Meeting Held On November 14Th 2023 Approved unaudited standalone results for the quarter and period ended 30th September 2023 |
Fri, 08 Dec 2023 |
|
|
|
|
|